Skip to contentI
Inspire Medical Systems, Inc.
I
INSPInspire Medical Systems, Inc. Q3 2021 · 10-Q
Revenue$61.69M$61.69M+72.1% vs Q3 2020 Net Income-$10.35M-$10.35MN/M vs Q3 2020 EPS Diluted-$0.38-$0.38N/M vs Q3 2020 Gross Profit$53,061,000+73.2% Operating Income
The same fiscal quarter, prior years. Thaler holds no estimates to compare against.
Inspire Medical Systems, Inc. · CIK 1609550 · Engraved from SEC EDGAR
Operating Cash Flowderived-$338,000N/M Free Cash Flowderived-$1,489,000N/M Margins · derivedGross margin86.0%+0.6 pt vs Q3 2020
Operating margin-15.9%+11.7 pt vs Q3 2020
Net margin-16.8%+12.2 pt vs Q3 2020
ended Sep 30, 2021 · filed Nov 2, 2021 · 33 d after period end